Zhi-Ying Luo
Overview
Explore the profile of Zhi-Ying Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiao C, Liu W, Luo Z, Li W, Li Y, Ren H, et al.
Clin Pharmacol Ther
. 2023 Dec;
115(3):545-555.
PMID: 38069481
Extensive investigations have been conducted regarding the potential correlation between blood type and the immune system, as well as cancer risk in the Southern Chinese population. However, the prognostic value...
2.
Liu R, Zou Y, Wang W, Chen J, Zhang L, Feng J, et al.
Nat Commun
. 2023 Nov;
14(1):7421.
PMID: 37973916
The gut microbiota may have an effect on the therapeutic resistance and toxicity of immune checkpoint inhibitors (ICIs). However, the associations between the highly variable genomes of gut bacteria and...
3.
Xiao C, Ren H, Chen H, Liu W, Luo Z, Li W, et al.
Front Pharmacol
. 2023 Apr;
14:1145456.
PMID: 37006996
Given the limitations of traditional pharmacology pedagogical method, diverse novel teaching methods have been widely explored. In this study, we performed a network meta-analysis (NMA) to evaluate the effects of...
4.
Gong J, Ren H, Peng S, Xing K, Fan L, Liu M, et al.
Phytomedicine
. 2022 Jan;
98:153942.
PMID: 35093672
Background And Objectives: Clinical guidelines and expert consensus do not yet recommend glycyrrhizic acid (GA) preparations, such as compound glycyrrhizin, diammonium glycyrrhizin, magnesium isoglycyrrhizinate (MGIG), et al., for the prevention...
5.
Gong J, Peng S, Xing K, Fan L, Tan S, Luo Z, et al.
Medicine (Baltimore)
. 2021 Mar;
100(11):e24423.
PMID: 33725933
The association between Glutathione S-transferase Pi 1(GSTP1) genetic polymorphism (rs1695, 313A>G) and cyclophosphamide-induced toxicities has been widely investigated in previous studies, however, the results were inconsistent. This study was performed...
6.
Li D, Zhu H, Luo Z, Chen Y, Song G, Zhou X, et al.
Pharmacogenomics
. 2020 Oct;
21(16):1169-1178.
PMID: 33094665
The aim of this study was to investigate whether variability in warfarin stable dose (WSD) could be influenced by vitamin K-related polymorphisms in patients with heart valve replacement. Twenty-nine vitamin...
7.
Li D, Luo Z, Chen Y, Zhu H, Song G, Zhou X, et al.
J Cardiovasc Pharmacol
. 2020 Apr;
76(1):71-76.
PMID: 32282500
Warfarin international normalized ratio (INR)-related phenotypes such as the percentage of INR time in the therapeutic range (PTTR) and INR variability are associated with warfarin adverse reactions. However, INR-related phenotypes...
8.
Xie X, Yu J, Zhang L, Luo Z, Ouyang D, Zheng L, et al.
Funct Integr Genomics
. 2018 Oct;
19(2):227-236.
PMID: 30343388
This study aimed to investigate the relationship between polymorphisms in the lipid metabolism-related gene PLA2G16 encoding Group XVI phospholipase A2 and the risk of colorectal cancer (CRC) in the Chinese...
9.
Wang C, Liu S, Xie X, Luo Z, Yang L, Tan Z
Diabetes Metab Syndr Obes
. 2018 Sep;
11:439-446.
PMID: 30174451
Introduction: The small peptide transporter 1 (PepT-1) and adipose phospholipase A2 (AdPLA) play a key role in the development of obesity. However, there are no data assessing the impact of...
10.
Liu M, He H, Zhang Y, Hu Y, He F, Luo J, et al.
Acta Pharmacol Sin
. 2017 Jan;
38(3):415-423.
PMID: 28112181
The highly variable pharmacokinetics and narrow therapeutic window of tacrolimus (TAC) has hampered its clinical use. Genetic polymorphisms may contribute to the variable response, but the evidence is not compelling,...